Home  /  Resource Library  /  Brentuximab Vedotin with Chemotherapy for Patients with Previously Untreated, Stage III/IV Classical Hodgkin Lymphoma: 5-Year Update of the ECHELON-1 Study

Brentuximab Vedotin with Chemotherapy for Patients with Previously Untreated, Stage III/IV Classical Hodgkin Lymphoma: 5-Year Update of the ECHELON-1 Study

ASH 2020: Long term results of a phase III trial investigating brentuximab vedotin combined with chemotherapy for first line treatment of Hodgkin lymphoma.